Illumina launches latest chemistry across most popular mid-throughput sequencers, enabling higher quality and greater speed for customers at lower cost
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
